Time to antibiotic administration in intra-amniotic infections: impact of cefoxitin monotherapy versus traditional antibiotic therapy
Antimicrobial Stewardship & Healthcare Epidemiology · 2026 · 6 (1)
DOI: 10.1017/ash.2026.10748 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Stewardship & Healthcare Epidemiology, online erschienen am 20.07.2026. Verfasst von Hannah Bischoff und 8 weiteren Autor:innen. Beteiligte Einrichtung: UH Rainbow Babies & Children's: UH Rainbow Babies and Children's Hospital, USA. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
This study addresses treatment of intra-amniotic infection (IAI) by comparing timely receipt of recommended antibiotic administration between cefoxitin and traditional antimicrobial therapy, ampicillin and gentamicin, with or without clindamycin.
Methods
This retrospective cohort study was conducted at a large, multi-site health system. The combination therapy group treated with ampicillin plus gentamicin, with or without clindamycin from June 2022 to May 2023, was compared to patients treated with cefoxitin from June 2023 to May 2024, following an institutional guideline update.
Participants
Pregnant individuals aged 16 and older with diagnosed or presumed IAI were included.
Results
Three hundred patients were included, 150 each in both the combination therapy and cefoxitin groups. Baseline characteristics were similar between the combination therapy and cefoxitin patients. Vaginal delivery was the most common mode of delivery, and rates of cesarean delivery were similar between groups. Most patients had a negative group B Streptococcus screen. Timely receipt of antimicrobials within 60–90 minutes of order entry occurred in significantly more patients in the cefoxitin group compared to combination therapy group (69.3% vs 4.7%, P < .001). Time to recommended therapy was significantly shorter in the cefoxitin group (76.4 ± 93.3 vs 183.7 ± 228.9 min, P < .001). There were no differences in mortality, 30-day infection-related readmission, or need for additional surgical/procedural intervention.
Conclusions
Cefoxitin for IAI significantly improves timeliness of recommended antibiotic treatment, aligning with current guideline recommendations for prompt therapy. The absence of differences in secondary outcomes supports the clinical efficacy of cefoxitin and its consideration as a first-line agent in the management of IAI.
Autor:innen und Institutionen
- UH Rainbow Babies & Children's: UH Rainbow Babies and Children's Hospital, USA.
- Pharmacy, Prisma Health Upstate, Greenville, SC, USA.
- Prisma Health Midlands, Columbia, SC, USA.
- University of South Carolina School of Medicine, Columbia, SC, USA.
ORCID-Profile: Hannah Bischoff, Sarah Tennant Withers, Caroline Jozefczyk, R Jake Crocker, Pamela Bailey
Zitieren
APA
Bischoff, H., Withers, S. T., Jozefczyk, C., Kohn, J., Crocker, R. J., Lewis, J., Ellison, C., Ewing, J. A., & Bailey, P. (2026). Time to antibiotic administration in intra-amniotic infections: impact of cefoxitin monotherapy versus traditional antibiotic therapy. Antimicrobial Stewardship & Healthcare Epidemiology, 6(1). https://doi.org/10.1017/ash.2026.10748
Vancouver
Bischoff H, Withers ST, Jozefczyk C, Kohn J, Crocker RJ, Lewis J, et al. Time to antibiotic administration in intra-amniotic infections: impact of cefoxitin monotherapy versus traditional antibiotic therapy. Antimicrobial Stewardship & Healthcare Epidemiology. 2026;6(1). doi:10.1017/ash.2026.10748
BibTeX
@article{Bischoff2026,
author = {Bischoff, Hannah and Withers, Sarah Tennant and Jozefczyk, Caroline and Kohn, Joseph and Crocker, R Jake and Lewis, Jasmine and Ellison, Carolyn and Ewing, Joseph A and Bailey, Pamela},
title = {Time to antibiotic administration in intra-amniotic infections: impact of cefoxitin monotherapy versus traditional antibiotic therapy},
journal = {Antimicrobial Stewardship & Healthcare Epidemiology},
year = {2026},
volume = {6},
number = {1},
doi = {10.1017/ash.2026.10748}
}
EUVIMED